J Am Dent Assoc. 1995 Jun;126 Suppl:1S-24S.
The scientific basis for caries risk assessment, prevention and treatment on an individual patient basis requires further development, specification and continuing validation. Still, current technologies and techniques, taken together, can provide enhanced capabilities over those that have been employed traditionally. Undoubtedly, the clinical tools for carrying out these responsibilities will be refined and expanded in the future in response to the changing clinical profile of caries in the population. For example, bacteriologic testing methods have become easier and more reliable, and will become more widely used. Other effective methods to detect the early, pre-cavitation stage of caries also should become more available in the future. Practitioners will be continually challenged and responsible for evaluating the effectiveness and value of emerging technologies in their practices and in light of their patients' needs. But how can this be accomplished best? Effectiveness claims will be made for new drugs and devices that come onto the market. There are several sources of information to assist the practitioner in making such decisions. The American Dental Association acceptance programs (voluntary) and the U.S. Food and Drug Administration compliance programs (law) provide standards and guidance as to product safety and effectiveness. Without such determinations, the practitioner must judge independently product claims and clinical studies. Marketing materials by themselves (advertisements, videos, pamphlets) may not be sufficient evidence of effectiveness particularly when scientific references supporting claims either are not provided or are inadequate. Peer-reviewed scientific literature in publications of the major scientific and professional associations can be viewed as generally reliable. Changing the way dental caries is managed in clinical practice will require integrating new scientific information and technology into workable clinical procedures. Dental education and third-party reimbursement issues must be addressed also but are beyond the scope of this document. Given that disease patterns are always changing in the population, dentists need to modify practice decisions using risk assessment. Ultimately, the goal for dentistry is that adult patients also will enjoy the same low level of caries experience that many children enjoy today.
基于个体患者进行龋齿风险评估、预防和治疗的科学依据,仍需进一步发展、细化并持续验证。尽管如此,当前的技术和方法结合起来,相较于传统应用的技术,能够提供更强的能力。毫无疑问,未来用于履行这些职责的临床工具将随着人群中龋齿临床特征的变化而不断完善和扩展。例如,细菌学检测方法已变得更加简便可靠,并将得到更广泛的应用。其他检测龋齿早期、龋洞形成前期阶段的有效方法在未来也应会更加普及。从业者将不断面临挑战,并负责根据患者需求评估新兴技术在其实践中的有效性和价值。但如何才能最好地做到这一点呢?市场上将会出现关于新药和新设备的有效性宣称。有多种信息来源可协助从业者做出此类决策。美国牙科协会的认可项目(自愿性质)和美国食品药品监督管理局的合规项目(法律规定)为产品的安全性和有效性提供了标准和指导。如果没有此类判定,从业者必须独立判断产品宣称和临床研究。仅靠营销材料(广告、视频、宣传册)可能不足以证明有效性,尤其是当支持宣称的科学参考文献未提供或不充分时。主要科学和专业协会出版物中经过同行评审的科学文献通常可被视为可靠的。改变临床实践中龋齿的管理方式需要将新的科学信息和技术融入可行的临床程序中。牙科教育和第三方报销问题也必须加以解决,但超出了本文档的范围。鉴于人群中的疾病模式一直在变化,牙医需要利用风险评估来调整实践决策。最终,牙科的目标是成年患者也能享有如今许多儿童所拥有的低龋齿发生率。